AstraZeneca (MEX:AZN1N) FFO


MEX:AZN1N AstraZeneca PLC MEX:AZN1N
84 GF Score
Price MXN3,263.65
GF Value MXN3,171.07
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is AstraZeneca FFO?

FFO (Funds from operations) only applies to REITs.

MEX:AZN1N
84GF Score
AstraZeneca PLC MEX:AZN1N
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AstraZeneca (MEX:AZN1N) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca stock appears to be overvalued. The current stock price of MXN3,263.65 is trading 2.9% above its estimated GF Value™ of MXN3,171.07. GuruFocus considers AstraZeneca to be Fairly Valued.

Key valuation signals for MEX:AZN1N:

  • FFO:
  • GF Value™: MXN3,171.07 vs. price of MXN3,263.65 (2.9% above fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the MEX:AZN1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AstraZeneca Business Description

Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
84GF Score

Get the complete analysis for MEX:AZN1N

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,263.65
Price
MXN3,171.07
GF Value